Back to Resource Library
Introducing Long-acting Injectable Lenacapavir as HIV Pre-exposure Prophylaxis: Implementation considerations

This guide, developed by UNAIDS, provides practical guidance for countries considering whether and how to introduce lenacapavir (LEN) as part of their HIV prevention response. It supports context-based decision-making on whether and how to introduce LEN, recognizing that decisions should reflect epidemiological need, health system readiness, PrEP programme maturity, financing, supply, and community priorities.